Clinical Trial Update: A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of GNC-038 Tetra-specific Antibody Injection for rheumatoid arthritis is currently recruiting. The sponsor is Sichuan Baili Pharmaceuti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• GNC-038 Tetra-specific Antibody Injection

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: RECRUITING